Form 4 for INSM INSMED Inc
Accepted 2024-08-14 00:00:00 ET · period of report 2024-08-12 · accession 0001628280-24-037226 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-14 | 2024-08-12 | INSM | Smith Michael Alexander | CLO | M - OptEx | $15.59 | +88.1K | 176.8K | +99% | +$1.37M |
| DM | 2024-08-14 | 2024-08-12 | INSM | Smith Michael Alexander | CLO | S - Sale+OE | $72.96 | -88.1K | 88.7K | -50% | -$6.43M |
| DM | 2024-08-14 | 2024-08-12 | INSM | Smith Michael Alexander | CLO | M - OptEx | $0.00 | -88.1K | 34.5K | -72% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-12 | M | A | 11,900 | $17.16 | 100,627 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-12 | M | A | 41,640 | $13.91 | 142,267 | D | — | — | |
| 3 | Common | Common Stock | 2024-08-12 | M | A | 34,530 | $17.07 | 176,797 | D | — | — | |
| 4 | Common | Common Stock | 2024-08-12 | S | D | 67,655 | $72.75 | 109,142 | D | — | — | (F1) This is the weighted average sales price representing 67,655 shares sold at prices ranging from $72.22 to $73.22 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 5 | Common | Common Stock | 2024-08-12 | S | D | 20,415 | $73.65 | 88,727 | D | — | — | (F2) This is the weighted average sales price representing 20,415 shares sold at prices ranging from $73.22 to $74.11 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 6 | Derivative | Stock Option (right to buy) | 2024-08-12 | M | D | 11,900 | $0.00 | 0 | D | $17.16 · — to 2027-05-17 | 11,900 Common Stock | (F3) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 7 | Derivative | Stock Option (right to buy) | 2024-08-12 | M | D | 41,640 | $0.00 | 0 | D | $13.91 · — to 2029-01-03 | 41,640 Common Stock | (F3) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 8 | Derivative | Stock Option (right to buy) | 2024-08-12 | M | D | 34,530 | $0.00 | 34,530 | D | $17.07 · — to 2032-05-11 | 34,530 Common Stock | (F4) The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the date of grant. |